N Martinez-Majander1,2, K Aarnio1,2, J Pirinen1,2,3,4, T Lumikari1,2, T Nieminen5, M Lehto3, J Sinisalo3, M Kaste1,2, T Tatlisumak1,2,6,7, J Putaala1,2. 1. Clinical Neurosciences, Neurology, University of Helsinki, Helsinki, Finland. 2. Department of Neurology, Helsinki University Hospital, Helsinki, Finland. 3. Department of Cardiology, Heart and Lung Center, Helsinki University Hospital and University of Helsinki, Helsinki, Finland. 4. Department of Clinical Physiology and Nuclear Medicine, HUS Medical Imaging Center, Helsinki University Hospital and University of Helsinki, Helsinki, Finland. 5. Internal Medicine, University of Helsinki, Helsinki University Hospital and South Karelia Central Hospital, Helsinki, Finland. 6. Department of Clinical Neuroscience, Institute of Neuroscience and Physiology, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden. 7. Department of Neurology, Sahlgrenska University Hospital, Gothenburg, Sweden.
Abstract
BACKGROUND AND PURPOSE: Embolic strokes of undetermined source (ESUS) are a recent entity, not yet thoroughly investigated in young stroke patients. The clinical characteristics and long-term risks of vascular events and all-cause mortality between young-onset ESUS and other aetiological subgroups were compared. METHODS: Patients with ESUS were identified amongst the 1008 patients aged 15-49 years with first-ever ischaemic stroke in Helsinki Young Stroke Registry, and primary end-points were defined as recurrent stroke, composite vascular events and all-cause mortality. Cumulative 15-year risks for each end-point were analysed with life tables and adjusted risks were based on Cox proportional hazard analyses. RESULTS: Of the 971 eligible patients, 203 (20.9%) were classified as ESUS. They were younger (median age 40 years, interquartile range 32-46 vs. 45 years, 39-47), more often female (43.3% vs. 35.7%) and had fewer cardiovascular risk factors than other modified TOAST groups. With a median follow-up time of 10.1 years, ESUS patients had the second lowest cumulative risk of recurrent stroke and composite vascular events and lowest mortality compared to other TOAST groups. Large-artery atherosclerosis and small vessel disease carried significantly higher risk for recurrent stroke than did ESUS, whilst no difference appeared between cardioembolism from high-risk sources and ESUS. CONCLUSIONS: In our cohort, ESUS patients were younger and had milder cardiovascular risk factor burden and generally better long-term outcome compared to other causes of young-onset stroke. The comparable risk of recurrent stroke between ESUS and high-risk sources of cardioembolism might suggest similarities in their pathophysiology.
BACKGROUND AND PURPOSE:Embolic strokes of undetermined source (ESUS) are a recent entity, not yet thoroughly investigated in young strokepatients. The clinical characteristics and long-term risks of vascular events and all-cause mortality between young-onset ESUS and other aetiological subgroups were compared. METHODS:Patients with ESUS were identified amongst the 1008 patients aged 15-49 years with first-ever ischaemic stroke in Helsinki Young Stroke Registry, and primary end-points were defined as recurrent stroke, composite vascular events and all-cause mortality. Cumulative 15-year risks for each end-point were analysed with life tables and adjusted risks were based on Cox proportional hazard analyses. RESULTS: Of the 971 eligible patients, 203 (20.9%) were classified as ESUS. They were younger (median age 40 years, interquartile range 32-46 vs. 45 years, 39-47), more often female (43.3% vs. 35.7%) and had fewer cardiovascular risk factors than other modified TOAST groups. With a median follow-up time of 10.1 years, ESUS patients had the second lowest cumulative risk of recurrent stroke and composite vascular events and lowest mortality compared to other TOAST groups. Large-artery atherosclerosis and small vessel disease carried significantly higher risk for recurrent stroke than did ESUS, whilst no difference appeared between cardioembolism from high-risk sources and ESUS. CONCLUSIONS: In our cohort, ESUS patients were younger and had milder cardiovascular risk factor burden and generally better long-term outcome compared to other causes of young-onset stroke. The comparable risk of recurrent stroke between ESUS and high-risk sources of cardioembolism might suggest similarities in their pathophysiology.
Authors: Kanjana S Perera; Danielle de Sa Boasquevisque; Purnima Rao-Melacini; Amanda Taylor; Anna Cheng; Graeme J Hankey; Sarah Lee; Joan Marti Fabregas; Sebastian F Ameriso; Thalia S Field; Antonio Arauz; Shelagh B Coutts; Marcel Arnold; Robert Mikulik; Danilo Toni; Jennifer Mandzia; Roland C Veltkamp; Elena Meseguer; Karl Georg Haeusler; Robert G Hart Journal: JAMA Neurol Date: 2022-05-01 Impact factor: 29.907
Authors: Hans-Christoph Diener; J Donald Easton; Robert G Hart; Scott Kasner; Hooman Kamel; George Ntaios Journal: Nat Rev Neurol Date: 2022-05-10 Impact factor: 44.711
Authors: Marion Boulanger; Linxin Li; Shane Lyons; Nicola G Lovett; Magdalena M Kubiak; Louise Silver; Emmanuel Touzé; Peter M Rothwell Journal: Neurology Date: 2019-07-23 Impact factor: 9.910
Authors: Joseph M Dardick; David Flomenbaum; Daniel L Labovitz; Natalie Cheng; Ava L Liberman; Charles Esenwa Journal: Sci Rep Date: 2021-01-11 Impact factor: 4.379
Authors: Muhammad K Ahmed; Haris Kamal; Jessica L Weiss; Annemarie Crumlish; Peyman Shirani; Robert N Sawyer; Ashkan Mowla Journal: Brain Circ Date: 2021-05-29
Authors: Jan Pawel Bembenek; Michal Adam Karlinski; Iwona Kurkowska-Jastrzebska; Anna Czlonkowska Journal: Neurol Sci Date: 2018-03-19 Impact factor: 3.307
Authors: Reetta Kivioja; Arto Pietilä; Nicolas Martinez-Majander; Daniel Gordin; Aki S Havulinna; Veikko Salomaa; Karoliina Aarnio; Sami Curtze; Jaana Leiviskä; Jorge Rodríguez-Pardo; Ida Surakka; Markku Kaste; Turgut Tatlisumak; Jukka Putaala Journal: J Am Heart Assoc Date: 2018-11-06 Impact factor: 5.501
Authors: Ali M Al Khathaami; Bayan Al Bdah; Abdulmjeed Alnosair; Abdulkarim Alturki; Rayan Alrebdi; Shorug Alwayili; Sulaiman Alhamzah; Fahad A M AlKhathaami; Nasser Alotaibi Journal: Stroke Res Treat Date: 2019-12-03